DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q2 2023 Earnings C

Operator: Good morning, ladies and gentlemen, and welcome to the DiaMedica Therapeutics Second Quarter 2023 Conference Call.

Related Keywords

Canada , Australia , Boston , Massachusetts , United States , Netherlands , China , Dan Hultberg , David Wambeke , Scott Kellen , Richard Kuntz , Rick Pauls , Francois Brisebois , Alex Nowak , Thomas Flaten , Professor Of Medicine At Harvard Medical School , National Academy Of Medicine , Diamedica Therapeutics Inc , Craig Hallum Capital Group , Nasdaq , Harvard Clinical Research Institute , Medtronic , National Institutes Of Health , Division Of Clinical Biometrics , Diamedica Therapeutics , Call Transcript August , Diamedica Therapeutics Second Quarter , Investor Relations , Cautionary Statement Note , Risk Factors , Chief Executive , Chief Financial , Chief Medical Officer , Chief Scientific Officer , Senior Vice President , Before Medtronic , Associate Professor , Harvard Medical School , Clinical Biometrics , Interventional Cardiologist , National Academy , National Institutes , Advancing Patient Care , Chief Business Officer , Lake Street , Craig Hallum Capital ,